GENETIC PREDICTIVE MODEL BASED ON SINGLE NUCLEOTIDE POLYMORPHISMS IN THE DNA REPAIR PATHWAY AND DRUG METABOLIS/TRANSPORT PHARMACOGENETICS IN THE PREDICTION OF RESPONSE AND TREATMENT OUTCOMES IN ACUTE MYELOID LEUKEMIA: